Structure |
Chemical Name |
CAS |
MF |
|
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
|
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
|
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
|
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
|
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
|
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
|
2’-deoxyinosine |
|
|
|
Anti-Ceftriaxong |
|
|
|
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
|
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
|
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
|
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
|
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
|
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
|
5-Mercapto-1H-tetrazole-1-methane sulphonic acid |
67146-22-9 |
C2H4N4O3S2 |
|
McMMAE |
863971-24-8 |
C49H78N6O10 |
|
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
|
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
|
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
|
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
|
4-MAR |
|
|
|
(R)-ethyl thiazolidine-4-carboxylate |
|
C6H11NO2S |
|
Ranolazine-d3 |
1054624-77-9 |
C24H33N3O4 |
|
5-BENZYLIDENEHYDANTOIN |
3775-01-7 |
C10H8N2O2 |
|
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
|
Clopidogrel camphorsulfonate |
120202-68-8 |
C26H32ClNO6S2 |
|
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |
130793-28-1 |
C29H55NO6 |
|
N4-Acetyl-2'-O-Methyl-cytidine |
113886-71-8 |
C12H17N3O6 |
|
4,4'-Dibromo-2,2'-diiodobiphenyl |
852138-89-7 |
C12H6Br2I2 |
|
Sterolazole intermediate |
|
|
|
2',3'-Anhydroinosine |
31766-13-9 |
C10H10N4O4 |
|
N-ForMyl- |
104872-27-7 |
C29H53NO5 |
|
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
|
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline |
190728-25-7 |
C17H16N2O3 |
|
2-Amino-4-bromo-3-fluorobenzoic acid |
1416013-62-1 |
C7H5BrFNO2 |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
|
Neratinib Maleate |
915942-22-2 |
C34H33ClN6O7 |
|
Oclacitinib Maleate(PF-03394197) |
1208319-27-0 |
C19H27N5O6S |
|
4,6,7-trihydroxycoumarin |
22649-24-7 |
C9H6O5 |
|
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
|
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
C18H18BrN5O2 |
|
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
|
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
|
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
|
Δ3-Flomoxef sodium |
|
|
|
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
|
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
|
5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide |
31127-80-7 |
C16H20I3N3O7 |
|
(+)-beta-Pinene oxide |
6931-54-0 |
C10H16O |
|
Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate |
64485-82-1 |
C7H9N3O3S |
|
1H-Tetrazole-1-acetic acid |
21732-17-2 |
C3H4N4O2 |
|
4-Methylimidazole |
822-36-6 |
C4H6N2 |
|
methyl 3-{[(tert-butoxy)carbonyl]amino}-5-iodothiophene-2-carboxylate |
1007171-35-8 |
C11H14INO4S |
|
ethyl 7-[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate |
446299-90-7 |
C30H29N3O4 |
|
6,7-dichloro-4-methyl- 2H-chromen-2-one |
923019-32-3 |
C10H6Cl2O2 |
|
3-(2-ETHOXYCARBONYL-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
877173-80-3 |
C15H25NO5 |
|
(3R,5S,2S,3S)-posaconazole |
|
|
|
methyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyrimidine-5-carboxylate |
1057682-17-3 |
C15H22N4O4 |
|
tert-butyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
△3-Cefuroxime |
|
|
|
Flomoxef Intermediate KDFA |
|
|
|
Polymethylhydrosiloxane |
9004-73-3 |
C5H11OSi* |
|
tert-butyl (S)-1-amino-4-fluoro-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(3R,4S,5R)-Oseltamivir |
|
|
|
(9H-fluoren-9-yl)methyl (R)-(3-(4-chlorophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
tert-butyl 4-bromo-3-(bromomethyl)thiophene-2-carboxylate |
|
|
|
Zanamivir |
139110-70-6 |
C18H26N2O10 |
|
1-Piperazinecarboxylic acid, 4-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-, 1,1-dimethylethyl ester |
1962174-33-9 |
C17H22N2O4 |
|
Prostaglandin E synthase 3 (PTGES3) Antibody |
|
|
|
(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione |
110351-94-5 |
C13H13NO5 |
|
13,14-dihydro Prostaglandin F2a |
|
|
|
benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate |
|
|
|
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
|
[2S-[2α(R*),3β]]-N-ForMyl- |
104872-28-8 |
C29H53NO5 |
|
7-DesMethylagoMelatine |
152302-45-9 |
C14H15NO2 |
|
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
899809-64-4 |
C9H11NO4 |
|
Aegelin |
456-12-2 |
C18H19NO3 |
|
1,2,4-cyclohexanetricarboxylic anhydride |
53611-01-1 |
C9H10O5 |
|
3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate |
104680-25-3 |
C10H13NO4S |
|
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(3S,4S,5S)-Oseltamivir |
|
|
|
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
|
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
|
3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL |
78573-45-2 |
C10H11F3O |
|
Δ3-Ceftiofur |
|
|
|
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
|
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
|
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
|
20-hydroxy Prostaglandin F2a |
|
|
|
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
|
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
|
S)-3-Cyano-5-methyl hexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
|
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
|
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
|
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
|
3-FLUOROINDOLE |
66946-81-4 |
C8H6FN |
|
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |